2024生物医学转化伦敦论坛 (2024 Biomedical Translational Research Forum – London)

论坛简介 (Introduction)

全英华人教授协会（ABCP）生命科学与健康专业委员会携手UKA和全英华人生命科学学会（CLSS）将于 2024年4月5日（周五）上午10：30举行2024生物医学转化伦敦论坛。
地点为伦敦大学学院，UCL IOE，Roon C3.11, 20 Bedford Way, London WC1H 0NS。
报名参会截止日期3月25日(报名请扫二维码)。所有参会者都有5-10分钟flash talk的机会展示自己的项目，请在报名时注明自己的报告题目。

The Association of British Chinese Professors (ABCP) Life Sciences and Health Special Committee, in collaboration with UKA and the Chinese Life Sciences Society in the UK (CLSS), will hold the 2024 Biomedical Translational Research Forum on April 5, 2024 (Friday), at 10:30 a.m.
Location: Jeremy Bentham Room (JBR), Wilkins Building (UCL main building), London WC1E 6BT.
The deadline for registration is the 25th March (please scan the QR code to register). All attendees will have a 5-10min flash talk opportunity to showcase their projects. Please indicate your presentation title when registering.

参会要求 (Attendance requirements)：

• 专家：ABCP会员及其团队成员；CLSS高年资会员
• 创业者：高校spin out company 代表
• 投资者：有成功投资高科技项目企业经历的机构代表及提供赞助的企业代表
  除了个别演讲者外（比如来自中国），不设网上参会名额
  参会人员需遵守大学、企业、机构 知识产权保护等规定及相关国家法律法规。活动组织者对此不承担任何责任。

  ---

• Experts: Members of ABCP and their team members; senior members of CLSS
• Entrepreneurs: Representatives from spin-out companies of universities
• Investors: Representatives from institutions with successful investments in high-tech projects
  Except for a few speakers (such as those from China), there are no online attendance available.
  Participants must comply with the intellectual property protection regulations of the university, corporation, or institution, as well as pertinent national laws and regulations. The organizers bear no responsibility in this regard.

特邀嘉宾 (Keynote speakers)：

• John Wood, FRS 皇家学会院士、英国国家医学科学院院士
• Bill Richardson, FRS 皇家学会院士、英国国家医学科学院院士
• Tomas Lindahl, FRS 2015年诺贝尔奖获得者、皇家学会院士、英国国家医学科学院院士
  

  ---

• John Wood FRS FMedSci, UCL
• Bill Richardson FRS FMedSci, UCL
• Tomas Lindahl FRS FMedSci, Nobel Laureate in Chemistry 2015

项目团队 (Speakers)：

曼彻斯特大学, 王涛教授团队 – 脑血管与神经退行性疾病
UCL, 刘朝宗教授团队 – 骨科生物材料与骨科疾病介入治疗
UCL, 李会良教授团队 – 胆固醇与神经退行性疾病
UCL, 周海燕博士团队 – RNA 治疗
伦敦玛丽女王大学, 王尧河教授团队 – 肿瘤病毒免疫治疗
伦敦玛丽女王大学, 吕永杰教授团队 – 肿瘤生物标记物及诊断
剑桥大学, 苏里教授团队 – AI/神经影像及AD
曼彻斯特大学, 王欣教授与张弘源博士 – 心衰新药
南安普顿大学, Xize Niu教授团队 – spinout company Droplet Scientific Ltd.
斯旺西大学, 夏志道博士团队 – From Research to Commercialisation: to Do, or Not to Do

届时, 君实生物 (HK1877; Yingge Chen, Secretary of the Board of Directors 和 Wenbing Yu, Assistant General Manager)，丰川资本 (副总裁 Steven Yuan), 英国超越等将分享他们的研发管线，融资，投资经验。

Professor Tao WANG, University of Manchester
Professor Chaozong LIU, UCL
Professor Huiliang LI, UCL
Dr Haiyan ZHOU, UCL
Professor Yaohe WANG, Queen Mary University of London
Professor Yongjie LU, Queen Mary University of London
Professor Li SU, University of Cambridge
Professor Xin Wang & Dr Hongyuan ZHANG, University of Manchester
Professor Xize Niu, University of Southampton
Dr Zhidao Xia, Swansea University

In addition, Junshi Biosciences (HK1877), FC Capital, Beyond Laboratory, etc., will share their research pipelines, financing, and investment experiences.